Fibrogen Stock Price on July 2, 2018

FGEN Stock  USD 2.58  0.14  5.74%   
Below is the normalized historical share price chart for FibroGen extending back to November 14, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of FibroGen stands at 2.58, as last reported on the 28th of March, with the highest price reaching 2.68 and the lowest price hitting 2.30 during the day.
IPO Date
14th of November 2014
200 Day MA
2.0923
50 Day MA
1.8593
Beta
0.664
 
Yuan Drop
 
Covid
If you're considering investing in FibroGen Stock, it is important to understand the factors that can impact its price. FibroGen is abnormally volatile given 3 months investment horizon. FibroGen secures Sharpe Ratio (or Efficiency) of 0.18, which denotes the company had a 0.18% return per unit of standard deviation over the last 3 months. We were able to analyze and collect data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 2.51% are justified by taking the suggested risk. Use FibroGen Mean Deviation of 8.09, downside deviation of 9.36, and Semi Deviation of 7.6 to evaluate company specific risk that cannot be diversified away.
  
At this time, FibroGen's Liabilities And Stockholders Equity is very stable compared to the past year. As of the 28th of March 2024, Capital Stock is likely to grow to about 1 M, though Total Stockholder Equity is likely to grow to (194 M). . As of the 28th of March 2024, Price Earnings Ratio is likely to drop to -0.32. In addition to that, Price To Sales Ratio is likely to drop to 0.55. FibroGen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1834

Best PortfolioBest Equity
Good Returns
Average ReturnsFGEN
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 13.7
  actual daily
96
96% of assets are less volatile

Expected Return

 2.51
  actual daily
49
51% of assets have higher returns

Risk-Adjusted Return

 0.18
  actual daily
14
86% of assets perform better
Based on monthly moving average FibroGen is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of FibroGen by adding it to a well-diversified portfolio.
Price Book
53.8258
Enterprise Value Ebitda
(0.61)
Price Sales
1.7481
Shares Float
83 M
Wall Street Target Price
1.25

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

About FibroGen Stock history

FibroGen investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for FibroGen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in FibroGen will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing FibroGen stock prices may prove useful in developing a viable investing in FibroGen
Last ReportedProjected for 2024
Common Stock Shares Outstanding97.3 M78.2 M
Net Loss-264.3 M-251.1 M

FibroGen Quarterly Net Working Capital

113.89 Million

FibroGen Stock Technical Analysis

FibroGen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of FibroGen technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of FibroGen trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

FibroGen Period Price Range

FibroGen March 28, 2024 Market Strength

Market strength indicators help investors to evaluate how FibroGen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading FibroGen shares will generate the highest return on investment. By undertsting and applying FibroGen stock market strength indicators, traders can identify FibroGen entry and exit signals to maximize returns

FibroGen Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for FibroGen's price direction in advance. Along with the technical and fundamental analysis of FibroGen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of FibroGen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether FibroGen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of FibroGen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fibrogen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fibrogen Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in FibroGen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.
Note that the FibroGen information on this page should be used as a complementary analysis to other FibroGen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Complementary Tools for FibroGen Stock analysis

When running FibroGen's price analysis, check to measure FibroGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FibroGen is operating at the current time. Most of FibroGen's value examination focuses on studying past and present price action to predict the probability of FibroGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FibroGen's price. Additionally, you may evaluate how the addition of FibroGen to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Is FibroGen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FibroGen. If investors know FibroGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FibroGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.536
Earnings Share
(2.92)
Revenue Per Share
1.518
Quarterly Revenue Growth
(0.21)
Return On Assets
(0.36)
The market value of FibroGen is measured differently than its book value, which is the value of FibroGen that is recorded on the company's balance sheet. Investors also form their own opinion of FibroGen's value that differs from its market value or its book value, called intrinsic value, which is FibroGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FibroGen's market value can be influenced by many factors that don't directly affect FibroGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FibroGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if FibroGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FibroGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.